-
Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings
Biotech Newswire
March 06, 2024
Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring.
-
The Narrative of Pharmaceuticals Bestowed with Endorsement and Later Reclaimed by Oblivion by the FDA
zhulikou431
March 06, 2024
This document endeavors to compile and elucidate data pertaining to instances where the U.S. FDA, in recent years, has rescinded market approval for pharmaceuticals previously sanctioned.
-
Cancer-Fighting CAR-T Cell Immunotherapy Potentially Induces New Cancers: An Analysis of Potential Safety Challenges
Big Cat of Medical Field
March 06, 2024
Recent reports have indicated that the National Medical Products Administration has addressed the potential carcinogenicity associated with CAR-T cell immunotherapy.
-
Block-buster Small Molecule Pharmaceuticals Approved by the NMPA in 2023
Yefenghong
March 06, 2024
According to data collated from the National Medical Products Administration (NMPA) official website, a total of more than 80 new drugs were granted inaugural approval within the domestic market.
-
ARCH Top-tier Pharmaceutical Venture Capital Firm: ARCH
Yefenghong
March 06, 2024
The R&D of new drugs is inextricably linked to substantial financial backing. Within this framework, the role of venture capital firms is immeasurable. Today, we spotlight the renowned venture capital entity, ARCH.
-
TechInvention Lifecare announces the ground breaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures
PharmaSources
February 29, 2024
The centre is strategically located close to the upcoming international airport in Navi Mumbai,India.
-
How could AI change drug development by ChatGPT
PharmaSources
February 26, 2024
Artificial Intelligence (AI) has the potential to significantly impact and revolutionize the field of drug development in several ways.
-
Vetter Contributes to Commercial Launches of Eight Customer Products in 2023
Biotech Newswire
February 18, 2024
February 14, 2024 Vetterannounces the successful commercialization of eight customer drug products as of the completion of 2023.
-
Freudenberg Medical Establishes Second Production Facility in Costa Rica
Biotech Newswire
February 18, 2024
February 14, 2024 Freudenberg Medicalannounced it is to establish a second manufacturing sitein Costa Rica.
-
Biointelect and CR2O Forge New Strategic Partnership to Provide Advanced End-To-End Commercialisation Solutions for The Life Science Sector Globally
Biotech Newswire
February 18, 2024
Driving more efficient and accelerated results from pre-clinical trials to commercialisation of new therapies for Australian, European and U.S. firms.